Watson consent decree
Executive Summary
Watson will hire an outside expert within 45 days to determine whether its "methods, facilities, and controls used at the Corona facility for manufacturing, processing, packing, holding, and distributing drugs are in compliance," the company's May 3 consent decree with FDA states. The first of the expert's annual reports is due in the first quarter of 2003. Watson has two pending ANDAs at the Corona, Calif. facility. As anticipated, Watson will not pay a fine or initiate a recall as a result of the consent decree (1"The Pink Sheet" April 1, p. 23)...
You may also be interested in...
Watson/FDA Consent Decree Will Not Involve Product Recalls, Firm Says
Watson does not expect to recall any products manufactured at its Corona, Calif. facility as a result of a proposed consent decree with FDA, CEO Allen Chao, PhD, told analysts in a March 28 conference call
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.